Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

Sarah Allford, Beverley J. Hunt, Peter Rose, +1

British Journal of Haematology

von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura

Sarah Allford, Paul Harrison, Andrew Lawrie, +3

British Journal of Haematology

ImmunologyPathologyThrombosisTranslational MedicineResidual Protease Activity +14

Mutation analysis and clinical implications of von Willebrand factor–cleaving protease deficiency

K. Assink, Rikke H.M. Schiphorst, Sarah Allford, +6

Kidney International

Disease MechanismGenetic DisorderVon WillebrandGeneticsPathogenesis +7

Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML

Sarah Allford, David Grimwade, Stephen E. Langabeer, +14

British Journal of Haematology

Molecular ScreeningPml/raralpha RearrangementsMixed-phenotype Acute LeukemiaImmunologyPathology +16

Successful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity factor VIII concentrate BPL 8Y

Will Lester, Michael D. Williams, Sarah Allford, +2

British Journal of Haematology

ThrombopoiesisThrombosisSevere Congenital TtpSuccessful TreatmentFactor Viii Preparations +10

Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the <i>PML/RARα</i> rearrangement in newly diagnosed AML

Sarah Allford, David Grimwade, Stephen E. Langabeer, +14

British Journal of Haematology

Molecular ScreeningMixed-phenotype Acute LeukemiaImmunologyMolecular BiologyPathology +18

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations

Nigel H. Russell, Charlotte S. Wilhelm-Benartzi, Jad Othman, +318

Journal of Clinical Oncology

von Willebrand factor‐cleaving protease activity in congenital thrombotic thrombocytopenic purpura

Sarah Allford, Paul Harrison, Andrew Lawrie, +3

British Journal of Haematology

ImmunohematologyImmunodeficienciesImmunologyPathologyThrombosis +16

Severe prekallikrein deficiency associated with homozygosity for an Arg94Stop nonsense mutation

David Wynne Jones, Geoffrey Russell, Sarah Allford, +5

British Journal of Haematology

Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemia.

R Powles, Seema Singhal, C Horton, +8

PubMed